Effect of Applying Phase 3 Trial Inclusion Criteria to MS Patients in Routine Clinical Care
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Applying Inclusion and Exclusion Criteria of Phase III Clinical Trials to Multiple Sclerosis Patients in Routine Clinical Care
Mult. Scler. 2021 Jan 20;[EPub Ahead of Print], KO Jalusic, D Ellenberger, P Rommer, A Stahmann, U Zettl, K BergerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.